It has been shown that expression of VEGF in eyes is regulated by advanced glycation end products generated by protracted diabetes symptoms and that this can be causally associated with diabetic retinopathy, characterized by an increased retinal neovascularization due to the action of VEGF [9]. This evidence concerns the gene VEGFA and diabetic retinopathy.